TRAIL-expressing T cells induce apoptosis of vascular smooth muscle cells in the atherosclerotic plaque. - Wikidata - awgldk - TriplyDB

TRAIL-expressing T cells induce apoptosis of vascular smooth muscle cells in the atherosclerotic plaque.

TRAIL-expressing T cells induce apoptosis of vascular smooth muscle cells in the atherosclerotic plaque.

http://www.wikidata.org/entity/Q36227892

about

Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease TRAIL/DR5 signaling promotes macrophage foam cell formation by modulating scavenger receptor expression Dendritic cells in atherosclerotic disease.Innate and adaptive immunity in atherosclerosis.Insufficient deactivation of the protein tyrosine kinase lck amplifies T-cell responsiveness in acute coronary syndrome Cellular and molecular regulation of spiral artery remodelling: lessons from the cardiovascular field Immune aging and rheumatoid arthritis.Statins reduce endothelial cell apoptosis via inhibition of TRAIL expression on activated CD4 T cells in acute coronary syndrome.Histone deacetylase inhibitor sensitizes apoptosis-resistant melanomas to cytotoxic human T lymphocytes through regulation of TRAIL/DR5 pathway.Immunomodulation strategies for preventing vascular disease of the brain and heart: workshop summary.Intranasal administration of recombinant TRAIL down-regulates CXCL-1/KC in an ovalbumin-induced airway inflammation murine model Immune aging and autoimmunity.TRAIL-deficiency accelerates vascular calcification in atherosclerosis via modulation of RANKL.Magnesium inhibits Wnt/β-catenin activity and reverses the osteogenic transformation of vascular smooth muscle cells.Association of TRAIL and Its Receptors with Large-Artery Atherosclerotic Stroke.Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage.Apoptosis in the skeletal muscle of untreated children with juvenile dermatomyositis: impact of duration of untreated disease.Correlation of plasma osteoprotegerin (OPG) and receptor activator of the nuclear factor κB ligand (RANKL) levels with clinical risk factors in patients with advanced carotid atherosclerosis.Characterization of a novel nonclassical T cell clone with broad reactivity against human renal cell carcinomas.Telomerase insufficiency in rheumatoid arthritis.A critical role for DAP10 and DAP12 in CD8+ T cell-mediated tissue damage in large granular lymphocyte leukemia.T cells in arteritis and atherosclerosis.Telomere Length, Proviral Load and Neurologic Impairment in HTLV-1 and HTLV-2-Infected Subjects Osteoprotegerin, vascular calcification and atherosclerosis.Vessel-specific Toll-like receptor profiles in human medium and large arteries.Trophoblast-mediated spiral artery remodelling: a role for apoptosis.Semi-Automated Curation Allows Causal Network Model Building for the Quantification of Age-Dependent Plaque Progression in ApoE-/- Mouse.The cooperative roles of inflammation and oxidative stress in the pathogenesis of hypertension.Mechanisms of immune complex-mediated neutrophil recruitment and tissue injury.CMV seropositivity determines epoetin dose and hemoglobin levels in patients with CKD Th17 cells and IL-17 are involved in the disruption of vulnerable plaques triggered by short-term combination stimulation in apolipoprotein E-knockout mice.Tumor necrosis factor superfamily molecules in acute coronary syndromes.Ischemia/reperfusion injury: The role of immune cells Role of unusual CD4+ CD28- T cells in acute coronary syndrome.Phenotypic and functional heterogeneity of macrophages and dendritic cell subsets in the healthy and atherosclerosis-prone aorta.Transcriptional regulation of tumour necrosis factor-related apoptosis-inducing ligand.Plasmacytoid dendritic cells: development, functions, and role in atherosclerotic inflammation.Tumor Necrosis Factor Related Apoptosis Inducing Ligand (Trail) in endothelial response to biomechanical and biochemical stresses in arteries.The life (and death) of CD4+ CD28(null) T cells in inflammatory diseases.Clinical consequences of circulating CD28-negative T cells for solid organ transplantation.

P2860

Q26747224-758334FD-B4D1-44F7-BB87-7838F494E1E4 Q27325727-4EB204C3-D298-4E9B-ABD5-3258FC32A0A6 Q33651897-BECB12D2-7AA0-4C97-9744-D843BB19E814 Q33659705-3872F2DE-28FC-4565-9D6C-0CA60B133DB7 Q33811114-1A2C9C0F-36D3-4CDE-9357-A626AD020E6E Q33901191-AAA3BEB4-EED9-439C-9680-3369F11934AB Q34036703-40C38AD2-EE04-4683-9A22-8E1A0B87FBF6 Q34036983-C7AD6026-3D9D-43EA-B30D-68F697F3CC4F Q34060387-16A8E085-6088-4EEE-94B9-3CA233EE26CE Q34578952-7EF8D1A3-CA96-4D38-B22C-BA43394139AA Q34704284-B8BB4DAC-FF64-4F04-AAB0-25BB1EE38221 Q34777989-CD0E34AD-2DA2-446E-97D8-A1DC39F1D635 Q34989869-11CF39A0-A1EC-45D8-BD5A-4254A33AB50B Q35107539-CE6F1CC5-D826-40A6-B710-32E445C82471 Q35763132-0EAB0B59-B10C-4C62-B20C-5E146A6510C9 Q36267204-E95A42BF-B85B-473A-A52D-B14A01B713FF Q36417352-7186D5B2-C4CD-4F10-AC31-349D32982537 Q36576768-389893E0-C144-4388-A64E-DE0BB4DBC167 Q36984489-D28BDB41-8341-4908-8287-08628773C790 Q37132884-987785E5-BBBF-42D2-9612-BE9754F2979D Q37151172-613FF25D-E283-4F4B-AA7F-E7E1FC8C7742 Q37192834-EBEDE3A0-AEC2-46DD-BB8A-2D72BC76F0C8 Q37203171-E86683AE-0B4A-4152-9B9C-89E67D9B8AC8 Q37310825-2C95C143-4B98-4431-ABF0-4D33217E9DED Q37357843-5B0FA3F0-FB2F-47A0-BB22-FB70F04A13CF Q37392325-9CFF79B5-7B85-4488-B043-F8631CE1A329 Q37401478-1F569161-6944-48F7-BE8A-205FE7FCD502 Q37433886-3789B079-1084-4AD2-8C8F-2DB24B5A3A00 Q37436638-DD45CF7D-33F9-447C-B24E-2898F1813CA7 Q37477756-8FD14979-26B9-45A5-A0CA-582CEACEB2C6 Q37729656-DCF3458B-ADE5-4D11-B4C1-338E557A5E98 Q37805514-355649C7-7138-4099-8A73-7CE1EEEBB3B8 Q37821238-14AB735C-E217-42D1-A443-431B410A7A2C Q37892982-AE820BC6-49E0-47C8-B7F9-E09605C3DEC1 Q37998021-20F04911-1947-42B6-8B5E-40C7833ECB05 Q38074861-2B5D8208-0066-4800-AFD8-84299C379389 Q38239650-A6204E67-FB4B-499D-92B2-1E88BBD3D6ED Q38479846-FD61AEEE-A1BE-4A0A-B11C-87F318C7F34A Q38550407-ACFA3B4B-442B-4E4B-BA90-6621424CD031 Q38568848-06055080-96C3-4284-816A-2E0902A32D6F

P2860

TRAIL-expressing T cells induce apoptosis of vascular smooth muscle cells in the atherosclerotic plaque.

http://www.wikidata.org/entity/Q36227892

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

TRAIL-expressing T cells induc ...... in the atherosclerotic plaque.

@ast

TRAIL-expressing T cells induc ...... in the atherosclerotic plaque.

@en

type

label

TRAIL-expressing T cells induc ...... in the atherosclerotic plaque.

@ast

TRAIL-expressing T cells induc ...... in the atherosclerotic plaque.

@en

prefLabel

TRAIL-expressing T cells induc ...... in the atherosclerotic plaque.

@ast

TRAIL-expressing T cells induc ...... in the atherosclerotic plaque.

@en

P1433

Q36227892-FF69D697-5CE5-475E-8B48-545F40EFE53E

P1476

Q36227892-F4A2D50A-D8DC-4248-AC9E-57158CB9E454

P2093

Q36227892-016F57E1-EA64-401D-A180-EB66ECBDBE66

Q36227892-5CBABF84-56F6-4792-9084-20FC1E0CA50B

Q36227892-CEDCFF88-1342-47BC-8485-B78693247B7B

Q36227892-E0F844E2-B6CB-49A5-8270-FFB024914EF8

Q36227892-E3E4CFFF-5FE8-426F-A663-A13A15DDED4C

Q36227892-EB0ED78B-72A2-44A6-8302-5E05CB97336F

P2860

Q36227892-0200F94B-6742-4187-A347-C227034F0570

Q36227892-044540A6-177F-4E2E-99EA-0E8E6937FCF9

Q36227892-072BE07E-2206-4138-A1A9-323F4A17538A

Q36227892-0CF83057-74C9-4F36-87FB-F17F06F4FCC3

Q36227892-10AB9C3B-517C-4BCD-B34B-1027BABA46E9

Q36227892-158F4B78-FC0B-4B98-9C8F-F3B602AEC15D

Q36227892-17EE7328-3AD6-4F92-9C76-92F9251A403B

Q36227892-21E73265-4265-4092-ACFC-F56C8FBD1B62

Q36227892-22AE081E-5285-4A7F-A63C-6A1E799A62AC

Q36227892-2AAA6573-8453-4FCF-A418-0E405223E103

P304

Q36227892-25A0E14F-CFE5-4500-A431-5A66E844A8E8

P31

Q36227892-193D8B7F-1FB9-46AD-999A-AA02F61E5F9F

P356

Q36227892-030BD267-D7B2-4550-BB69-F925DD1DFA51

P407

Q36227892-254D2620-E178-432A-8E01-BA0A54827EDC

P433

Q36227892-391753A3-8763-41BA-B44A-9013DCAB340E

P478

Q36227892-D2B12918-7A79-4895-9E21-B344A0CA4E4D

P577

Q36227892-48B61DFF-E805-469B-A43A-F78D2AD8AEBE

P5875

Q36227892-15772650-FB3C-4524-AE4F-9ABDB5D037FA

P698

Q36227892-EFC74648-B2D1-4D5D-A0DB-CDE0094A0F14

P921

Q36227892-69ADD912-BB01-46D5-AC10-3C3F1FAF0011

P932

Q36227892-C62B0D6E-D620-4575-9046-F033C66D27F9

P356

P1433

Journal of Experimental Medicine

P1476

TRAIL-expressing T cells induc ...... in the atherosclerotic plaque.

@en

P2093

Alexander Niessner

http://www.w3.org/2001/XMLSchema#string

Cornelia M Weyand

http://www.w3.org/2001/XMLSchema#string

Jörg J Goronzy

http://www.w3.org/2001/XMLSchema#string

Kayoko Sato

http://www.w3.org/2001/XMLSchema#string

Robert L Frye

http://www.w3.org/2001/XMLSchema#string

Stephen L Kopecky

http://www.w3.org/2001/XMLSchema#string

P2860

The receptor for the cytotoxic ligand TRAIL

Identification and characterization of a new member of the TNF family that induces apoptosis

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB

Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice

CD4+,CD28- T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems.

Safety and antitumor activity of recombinant soluble Apo2 ligand.

Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity.

Is there a vulnerable plaque?

Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques.

P304

239-250

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20051062

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

203

http://www.w3.org/2001/XMLSchema#string

P577

2006-01-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7354838

http://www.w3.org/2001/XMLSchema#string

P698

16418392

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

2118078

http://www.w3.org/2001/XMLSchema#string